3 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 32165486 | The HDAC and PI3K dual inhibitor CUDC-907 synergistically enhances the antileukemic activity of venetoclax in preclinical models of acute myeloid leukemia. | 2021 May 1 | 1 |
2 | 32459381 | CUDC-907, a novel dual PI3K and HDAC inhibitor, in prostate cancer: Antitumour activity and molecular mechanism of action. | 2020 Jul | 1 |
3 | 30819918 | Antileukemic activity and mechanism of action of the novel PI3K and histone deacetylase dual inhibitor CUDC-907 in acute myeloid leukemia. | 2019 Nov | 1 |